Peter Sommerness | President and CEO
Pete joined Respicardia as CEO in January of 2018. Prior to Respicardia, Pete was a Partner in the healthcare practice of McKinsey & Company, a global strategy consulting firm. Pete has nearly 20 years of experience in the medical device space, including over 12 years of operating experience at Guidant Corporation and Boston Scientific – across cardiac rhythm management (CRM) and cardiac electrophysiology (EP). Pete held leadership roles in field sales, market development, upstream marketing and portfolio, and most recently led the expansion of Boston Scientific’s Cardiac Electrophysiology business as VP and General Manager. Pete holds B.A., B.E. and M.E. degrees in Engineering from Dartmouth College and an M.B.A. in Finance with high honors from the Booth School of Business at the University of Chicago.
Robin Germany, M.D. | Chief Medical Officer
Dr. Robin Germany brings a wealth of respiratory and cardiovascular experience to Respicardia, where she serves as the Chief Medical Officer. Prior to joining Respicardia, she was the Director of Heart Failure Treatment and Medical Director of the Heart, Lung and Vascular Clinic at the University of Oklahoma. She followed her training in cardiovascular diseases at the University of Oklahoma with additional training in heart failure and electrophysiology. Her research focused on utilizing implantable devices to improve the care of heart failure patients. While serving as Chief Medical Officer for Respicardia, Dr. Germany retains her title of Clinical Assistant Professor at the University of Oklahoma.
Tim Hauch | Chief Financial Officer
Tim leads the financial and business development operations at Respicardia, bringing his industry expertise from his role as Vice President of Business Development with start-up superDimension, along with seventeen years at Medtronic. His prior roles included responsibilities for identifying key growth markets and defining acquisition targets, as well as leading cross-functional teams through acquisition, investment, license, divestiture and development transactions. Tim’s breadth of experience encompasses both public and private M&A transactions as well as both sides of strategic investments. He received a B.A. from the University of Wisconsin-Oshkosh and earned an M.B.A. from the University of Chicago Booth School of Business. Tim also passed the CPA exam.
Collin Anderson | Vice President of Marketing and Market Access
Collin brings over 15 years of medical device marketing experience to Respicardia, including expertise in both mature and emerging products at Boston Scientific’s Cardiac Rhythm Management and Interventional Cardiology divisions. Most recently, he served as Vice President of Global WATCHMAN™ Marketing where he led U.S commercialization and category development of the percutaneous left atrial appendage closure market. Collin received a B.S. in Civil Engineering with honors from North Dakota State University and earned his M.B.A. with distinction from the Tuck School of Business at Dartmouth College.
Todd Goblish | Vice President of Research and Development/Operations
Todd leads the R&D and operations efforts at Respicardia, bringing extensive experience in implantable and neurostimulation medical technologies. His prior experience includes VP of R&D at Pulmonetic Systems whose product successes led to their acquisition by Viasys Healthcare, followed by Cardinal Health. Prior to Pulmonetic Systems, Todd held various engineering management positions over nine years with the Cardiac Rhythm Management and Neurological Divisions of Medtronic. He holds a B.S. in Electrical Engineering from Marquette University and an M.S. in Computer Engineering from National Technological University.
Timothy Meyer, PhD | Vice President of Clinical Affairs
Tim has more than 13 years of experience of global clinical trials and risk management in the medical device industry preceded by an additional 9 years in academic research and teaching. Most recently he served as Clinical Director for global data management, Biostatistics and Electrophysiology Trial Management for Rhythm Management at Boston Scientific where he was responsible for the global clinical strategy for Electrophysiology trials and Risk Management as well as helping build a clinical structure in the Asia Pacific region. He has experience in all types of clinical trials and has numerous publications in the cardiovascular and implantable device space. Tim holds a B.A. in Zoology and History from the University of Wisconsin-Madison, an M.S. in Physiology from the University of North Dakota and a PhD in Movement Science from Washington University in St. Louis, MO.
Frank Piskolich, J.D. | General Counsel
Frank has more than sixteen years of legal experience in the medical device industry preceded by eleven years in engineering and leadership. Frank is responsible for all legal functions within Respicardia, including risk management, intellectual property and disputes. Prior to joining Respicardia Frank represented a range of clients while practicing law at Fredrikson and Byron, P.A. and is licensed to practice before the United States Patent and Trademark Office and the federal and state courts of Minnesota. Frank holds a Bachelor of Science degree in Chemical Engineering from Rose-Hulman Institute of Technology and a Juris Doctorate from the University of Minnesota Law School where he graduated cum laude and was a managing editor on the Minnesota Law Review.
Kevin Bentley | Executive Director of Regulatory Affairs and Quality
Kevin joined Respicardia in December of 2017. Kevin has over 30 years of experience developing, implementing, and improving quality management systems for both well-established and early-stage medical device companies. For the past 20 years, Kevin has held the top leadership roles in Regulatory and Quality where he has executed regulatory strategies across various types and classes of medical devices. Kevin holds a BS in Chemistry from the Rochester Institute of Technology and was RAC certified by the Regulatory Affairs Professional Society in 2004.